Last Price
Where today's price sits in its 52-week range
ACI Formulations PLC ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটি ভালো অবস্থায় আছে (আমাদের বিশ্লেষণে 100-এর মধ্যে 67)। কোম্পানিটি লাভজনক। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক কম। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 1.6%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Buy
Long-term holdGood company, but share is quiet
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks cheap right now — priced below its usual level.
P/E Ratio
19.5
Price per ৳1 of yearly earnings
Dividend Yield
1.60%
Annual cash return on the price
P/B Ratio
2.0
Price per ৳1 of net assets
Trading at 19.5 — below its 5-year average of 25.6.
The raw figures behind the verdict — for the curious.
EPS
৳7.85
Earnings per share (latest year)
P/E Ratio
16.2
Price you pay per ৳1 of earnings
Dividend Yield
1.60%
Annual cash return on the price
Reserve & Surplus
৳306 Cr
Company's accumulated savings
Total Loan
৳364 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Made a profit every year for 5 years.
Earnings Per Share
Profit you earn per share
Earnings per share have been growing — ৳7.8 latest.
Yearly Cash Dividend
% of face value
📢 New 25% dividend just declared
Paid a dividend every year for 5 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Down 1.0% in the past week, lagging the overall market, on heavier-than-usual trading.
Past week
-1.0%
Price move over 7 days
Vs market
-1.7%
Ahead/behind the DSEX index
Trading volume
1.4×
vs its normal volume
Up days
3/7
Green days this week
52-week spot
85%
Position in 1-year range
Trades around ৳1.6 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
ACIFORMULA scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| ACIFORMULA | 67 | ৳153 | +1.4% | 19.5 | +1.6% | +10.4% |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.
Good sign — big institutions raised their stake from 22.2% to 23.4% since Jun 2025. People close to the company are buying.
Owners (sponsors) hold 66% — heavily invested in the company's success.
Recent news and announcements about this company.